ACHV
Achieve Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$6.61
+3.53%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.20
- Revenue estimate
- $10.6M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.80
- EPS estimate
- -$0.16
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -92.2%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $16
- PT range
- $13 – $18
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.16 | -$0.80 | Miss -385.20% | — |
| May 12, 2026 | -$0.30 | -$0.19 | Beat 36.67% | — |
| Mar 24, 2026 | -$0.27 | -$0.28 | Miss -3.70% | — |
| Nov 6, 2025 | -$0.24 | -$0.28 | Miss -16.67% | — |
| Aug 7, 2025 | -$0.37 | -$0.37 | In line | — |
| Mar 11, 2025 | -$0.30 | -$0.36 | Miss -20.00% | — |
| Nov 7, 2024 | -$0.26 | -$0.36 | Miss -38.46% | — |
| Aug 13, 2024 | -$0.22 | -$0.25 | Miss -13.64% | — |
| May 9, 2024 | -$0.24 | -$0.26 | Miss -8.33% | — |
| Nov 9, 2023 | -$0.34 | -$0.34 | In line | — |
| Aug 14, 2023 | -$0.41 | -$0.43 | Miss -4.88% | — |
| Mar 16, 2023 | -$0.90 | -$0.83 | Beat 7.78% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026